The PZN is a nationwide standardized identification number for proprietary medical products in Germany enabling a well-defined attribution of a pharmaceutical product including, for example, name, package size and defined daily dose (DDD).
This enabled a well planned and collaboratively supported system to be built and implemented using consistent standards for data collection, management, reporting and use.
For example, a carefully selected KOP may enable a well to be drilled in less time and at lower cost, but problem formations or shallow reservoir targets can place constraints on where the KOP can be located.
This ongoing commitment has enabled a well trained network of experts to effectively reach more Palestinians in need.
The identification of specific problem areas will enable a well-informed consideration of the necessary next steps for improved prediction of energy extraction.
The chapter concludes that to enable a well-integrated system to be created, the electrical engineer needs to have both a complete operational specification and a mechanically completed functional specification.
It enables a well-powered, clinically relevant dichotomous outcome (full recovery versus not) to be studied.
The pharmaceutical identification number enables a well-defined attribution of a pharmaceutical product including for example name, package size, defined daily dose (DDD) and price.
To enable a well-powered GWAS for osteoarthritis, we formed the arcOGEN Consortium, a UK-wide collaborative effort aiming to scan genome-wide over 7500 osteoarthritis cases in a two-stage genome-wide association scan.
To enable a well-powered genome-wide association study (GWAS) for osteoarthritis, the authors have formed the arcOGEN Consortium, a UK-wide collaborative effort aiming to scan genome-wide over 7500 osteoarthritis cases in a two-stage genome-wide association scan.
As technologies improve, the standards change as well, enabling a virtuous cycle of improvement.
